scispace - formally typeset
M

Michael Markert

Researcher at Boehringer Ingelheim

Publications -  26
Citations -  604

Michael Markert is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Telemetry & Safety pharmacology. The author has an hindex of 12, co-authored 23 publications receiving 523 citations.

Papers
More filters
Journal ArticleDOI

Effects of isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl on physiological variables continuously measured by telemetry in Wistar rats.

TL;DR: The anaesthesias influenced very differently the cardiovascular parameters measured in Wistar rats, and the long wake-up and recovery period suggest the need for prolonged monitoring.
Journal ArticleDOI

Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization.

TL;DR: The aspects for developing a strategy for the preclinical testing of drug candidates for proarrhythmic potential are presented and the validation of such a strategy and its utility in drug development is now well established and recommended, independent from future regulatory requirements.
Journal ArticleDOI

Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies

TL;DR: It is concluded that ECG data from toxicological studies can offer complementary ECGs data that can strengthen a risk assessment, but for the great majority of standard toxicity studies conducted, the ECGs collected do not permit an adequate assessment of drug-induced effects on the QT interval with the sensitivity expected from the ICH S7B guidelines.
Journal ArticleDOI

Evaluation of cardiovascular and ECG parameters in the normal, freely moving Göttingen Minipig.

TL;DR: These are the first data documenting the course of systemic arterial and ventricular hemodynamic parameters in the freely moving Göttingen Minipig over 24 h, and may serve as a basis for future studies in which drug effects are studied in these animals.
Journal ArticleDOI

Optimizing the experimental environment for dog telemetry studies.

TL;DR: This study demonstrated that the quality of the acquired cardiovascular data for conscious dogs is dependent on the pen configuration and group make-up during a study.